Patents by Inventor Murali Mohan Bommana

Murali Mohan Bommana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Orally Disintegrating Tablet Formulation For Enhanced Bioavailability
    Publication number: 20190083403
    Abstract: In some aspects of the present invention is a formulation comprising a solid dispersion or intimate mixture of a poorly water soluble drug and an ionic polymer surprisingly exhibiting fast disintegration of tablet.
    Type: Application
    Filed: November 20, 2018
    Publication date: March 21, 2019
    Applicant: Kashiv Pharma, LLC
    Inventors: Jelena Djordjevic, Murali Mohan Bommana, Wantanee Phuapradit, Navnit H. Shah, Christopher A. Pizzo
  • Orally disintegrating tablet formulation for enhanced bioavailability
    Patent number: 10195150
    Abstract: In some aspects of the present invention is a formulation comprising a solid dispersion or intimate mixture of a poorly water soluble drug and an ionic polymer surprisingly exhibiting fast disintegration of tablet.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: February 5, 2019
    Assignee: Kashiv Pharma, LLC
    Inventors: Jelena Djordjevic, Murali Mohan Bommana, Wantanee Phuapradit, Navnit H. Shah, Christopher A. Pizzo
  • ENHANCED ABUSE-DETERRENT FORMULATIONS OF OXYCODONE
    Publication number: 20180303757
    Abstract: The present technology relates to an extended-release solid oral pharmaceutical composition, comprising a cured blend of a melt-extruded first component and a second component, wherein the melt-extruded first component comprises a therapeutically effective amount of an opioid or a pharmaceutically acceptable salt thereof, at least one PEO polymer, and a stabilizing agent; and the second component comprises at least one PEO polymer and an oxidative stabilizing agent. The extended-release pharmaceutical compositions of the present technology provide crush-resistant and abuse-deterrent formulations featuring enhanced heat stability, resistance to drug segregation, and resistance to alcohol-induced dose dumping.
    Type: Application
    Filed: October 21, 2016
    Publication date: October 25, 2018
    Applicant: KASHIV PHARMA LLC
    Inventors: Siddhartha Banerjee, Navnit H. Shah, Gaurang Patel, Murali Mohan Bommana, Ashish Chatterji, Anita Kumar, Petra Inbar, Furong Liu, Srinivas Kone, Priti L. Jagani, Wantanee Phuapradit
  • ORALLY DISINTEGRATING TABLET FORMULATION FOR ENHANCED BIOAVAILABILITY
    Publication number: 20160120809
    Abstract: In some aspects of the present invention is a formulation comprising a solid dispersion or intimate mixture of a poorly water soluble drug and an ionic polymer surprisingly exhibiting fast disintegration of tablet.
    Type: Application
    Filed: December 19, 2013
    Publication date: May 5, 2016
    Applicant: KASHIV PHARMA, LLC
    Inventors: Jelena Djordjevic, Murali Mohan Bommana, Wantanee Phuapradit, Navnit H. Shah, Christopher A. Pizzo